[HTML][HTML] T cell receptor repertoire characteristics both before and following immunotherapy correlate with clinical response in mesothelioma
H Vroman, G Balzaretti, RA Belderbos… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Background Malignant pleural mesothelioma (MPM) is a highly lethal malignancy in need
for new treatment options. Although immunotherapies have been shown to boost a tumor …
for new treatment options. Although immunotherapies have been shown to boost a tumor …